Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I watched the latest video call and they said the available cash is sufficient to cover them until probability early next year .
From the latest trading update :
Cash: $13.9m as of 31 December 2023
For the year ended December 31, Shield said it had delivered USD17.5 million in revenue, up nearly three-fold from USD6.2 million in 2022.
28 Sep 2023 RNS:
The Company is also pleased to announce that it has secured a US$20m senior secured debt facility from SWK (the "SWK Financing"), a life science-focused specialty finance company catering for small and mid-sized commercial-stage companies.
NO i have NOT BOUGHT YET as just done some due diligence and i think there funds must be tight .SO I AM HOLDING OF FOR NOW
Was this your 'small position' mate? ;)
09-Apr-24 09:48:01 1.72 1,150,000 Buy* 1.65 1.75 £19.78k
THIS is going to turn soon taking a small postion
No big selling reported yet.
Same here mate & I expect many have done the same last week to realise the loss before the end of the tax year ;)
I sold by shares on Friday to realise the loss. Bought back in my ISA this morning. Added a little more as well
I think people will start to buy in as new tax yr, and may be this is low of the sp. Well hope so,
It appears that a fund is attempting to trigger as many PIs stop losses as possible before the results are released to load up on the cheap until the share price starts to show some resistance/bounce back
They have what's supposed to be a world class product but the management must be worse than useless. What the next step? Is it a case of peopke bailing before results?
Not sure this will ever recover any meaningful value. Zero positivity from the market.
All time low so far. How much lower will this go.
No good drop drop every week
BUT of late it is hit and miss . THESE 500000 buys are intresting
Lost loads too. Kept a minimal amount invested. No plans to increase. If only they’d reissue the vote for a buyout at 6p 😂
The whole thing is an unmitigated disaster. There is nothing positive about any of it. Wish I hadn’t bought the shares. Now stuck with them
Could be a trap, to sucker in some buyers.
Given the lack of an update since the last RNS, this one firmly remains, IMO, a barge-pole stock and one that should be under investigation, as I have said before.
2P SEEMS OK has stx stopped falling
Emcure is definitely not a small or zombie company.
A global company with more than 10.000 employees
https://www.emcure.com/about-us-overview/
Anyone who is familiar with he world wide rights of Ferric Maltol?
I found a new registration of a Ferric Maltol trial at the Indian FDA (CDSCO) by a company called Emcure Pharma.
CDSCO grant a bioequivalence study.
But there were no information no hint about STX or AOP.
India is a not unimportant market.
https://medicaldialogues.in/news/industry/pharma/conduct-bioequivalence-study-cdsco-panel-tells-emcure-pharmaceutical-on-ferric-maltol-capsules-126248
Pain Hustlers-film on Netflix-based on a true story of a company selling a painkiller , building out its team & ultimately transpired to be scam, the founder being a billionaire from the companys success until it unravelled.Interesting embellishment of the lengths sales folk may go to in the US to get their sale & encourage Drs to prescribe.Emily Blunr excellent !
Yep- I emailed them to complain & raise my concerns & was totally fobbed off - despite many selling ahead of the 8p raise - all of whom should have been very easy to identify
Yes, but also the fault of the regulatory authorities for so rarely doing their job, when it comes to investigating so many AIM operations. Clear patterns of insider trading, front running raises, outright lies in RNS's etc.
Better off saving that tax payer money by getting rid. At the same time, removing the veneer of protection that does not seem to exist anyway. Even when a dodgy company does get caught, the consequences for the directors are never severe enough IMO. Such is life. GLA.
Greg is a great snakeoil salesman but his credentials as ceo of a quoted company are clearly suspect.The recent numbers debacle was a disgrace,we have heard nothing tangible about Canada ,South Korea or China & Norgine continue to progress in their substantial territories at a snails pace + the last 8p raise was a disgrace & destroyed shareholder value.At some point we will either go into Admin or be bought cheaply by AOP & we shareholders will,mostly,lose a substantial amount of our investment - but all our own fault!
There is no two ways about it STX absolutely has to see a significant operational turnaround before their next cash raise or shareholders are going to be diluted to oblivion - that's the short term risk now and explains the current SP.
There's a reasonable gamble to be had at 2p heading into April and the next quarterly results but it's certainly high risk, most would rather stay on the sidelines and buy back in on confirmation of better results.